Selected Drugs Clear All
MultiCheck Results
- 10
Interactions
Avoid/Use Alternative |
||
|
Myzilra
(levonorgestrel/ ethinyl estradiol) + Syeda
(drospirenone/ ethinyl estradiol) |
||
Avoid/Use Alternativeethinyl estradiol (contraceptive) + ethinyl estradiol (contraceptive) avoid combo: combo may incr. risk of HTN, thromboembolism, endometrial hyperplasia, other adverse effects (additive effects, duplicate therapy) levonorgestrel (contraceptive) + drospirenone (contraceptive) avoid combo: combo may incr. risk of thromboembolism, other adverse effects (additive effects, duplicate therapy) |
||
Monitor/Modify Tx |
||
|
Jentadueto XR
(linagliptin/ metformin) + Myzilra
(levonorgestrel/ ethinyl estradiol) |
||
Monitor/Modify Txlinagliptin + ethinyl estradiol (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) linagliptin + levonorgestrel (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) metformin + ethinyl estradiol (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) metformin + levonorgestrel (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) |
||
|
Jentadueto XR
(linagliptin/ metformin) + Syeda
(drospirenone/ ethinyl estradiol) |
||
Monitor/Modify Txlinagliptin + drospirenone (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) linagliptin + ethinyl estradiol (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) metformin + drospirenone (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) metformin + ethinyl estradiol (contraceptive) monitor glucose: combo may decr. antidiabetic agent efficacy (antagonistic effects) |
||
Additional Considerations |
||
|
tenofovir alafenamide
in Descovy
|
||
|
tenofovir alafenamide (prodrug) converted to tenofovir |
||